Discover how AT&T's strategic acquisitions and long-term approach may benefit patient investors as legacy challenges lessen.

The Swiss pharmaceutical company is said to be preparing an offer exceeding $70 per share for the U.S.-based biotech firm, ...

Curreen Capital was up 9% in the quarter. In July we sold our shares in Enhabit. We also bought a small position in Thinkific ...

Amazon remains fundamentally strong with innovation, AI, and robotization driving long-term value and growth potential. Learn ...

Alpine Income Property Trust (PINE) is rated a Strong Buy due to clear undervaluation, high-quality assets, and an attractive ...

U.S. Treasury Secretary Scott Bessent said negotiators had “a successful framework” for the leaders’ discussion, following ...

The Fed is expected to cut rates by 25 bps in October as structural labor issues and policy risks fuel a deeper downturn.

Nextracker posts 42% YoY revenue growth, strong margins, and record backlog in Q2 FY26. Discover why its outlook justifies a ...

First Internet Bancorp trades at a 50% discount to book with improving outlook and strong long-term EPS potential. Learn why ...

The Fed is expected to cut rates in October with a focus on QT policy as liquidity remains stable. Learn why QT may run ...

Hercules Capital has struggled recently and remains the second most expensive BDC with a bullish long-term case. Learn why ...

Biotech and biopharma M&A activity has surged in recent weeks, sparking a strong sector rally and renewed optimism. Learn why ...